1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
FEATURED COMPANIES
- B. Braun Melsungen AG
- Smith & Nephew Plc
- Stryker Corp.
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Global Femoral Stems Market: About this market
The femoral stems market analysis considers sales from both cementless femoral stems and cemented femoral stems. Our analysis also considers the sales of femoral stems in Asia, Europe, North America, and ROW. In 2018, the cementless femoral stems segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as bone regeneration and their ability to adapt to different bone structures will play a significant role in the cementless femoral stems segment to maintain its market position. Also, our global femoral stems market report looks at factors such as the increasing prevalence of OA, osteoporosis, and RA, increasing number of hip replacement surgeries, and advances in the femoral stem. However, high cost of hip replacement surgeries and declining reimbursements, shortage of skilled orthopedic surgeons, and limitations of femoral stems may hamper the growth of the femoral stems industry over the forecast period.
Global Femoral Stems Market: Overview
Advances in femoral stems
Femoral stems have undergone significant improvements in terms of material and design. The use of tapered titanium stems has outplaced coated cobalt-chromium stems. Tapered titanium stems offer ease of insertion, less-stress shielding, less blood loss, less thigh pain, leading to short hospital stays. Thus, manufacturers have increased R&D efforts to introduce femoral stems with advanced designs and materials, making them more durable, long-lasting, and dependable. This will lead to the expansion of the global femoral stems market at a CAGR of nearly 4% during the forecast period.
The increasing demand for short stems among young patients
As many young and active patients are undergoing hip replacement, there is an increasing demand for implants that are durable, highly functional, and amenable for future successful revision. Short stems can be easily inserted through minimally inserted surgeries (MIS) and require less bone removal. They reduce or eliminate anterior thigh pain, facilitate physiological proximal bone loading providing better pain relief, radiographic stability, and improved functions. This development is expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of several major players, the global femoral stems market is moderately concentrated. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of few leading femoral stems manufacturers, that include B. Braun Melsungen AG, Johnson & Johnson Services Inc., Smith & Nephew Plc, Stryker Corp., Zimmer Biomet Holdings Inc.
Also, the femoral stems market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The femoral stems market analysis considers sales from both cementless femoral stems and cemented femoral stems. Our analysis also considers the sales of femoral stems in Asia, Europe, North America, and ROW. In 2018, the cementless femoral stems segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as bone regeneration and their ability to adapt to different bone structures will play a significant role in the cementless femoral stems segment to maintain its market position. Also, our global femoral stems market report looks at factors such as the increasing prevalence of OA, osteoporosis, and RA, increasing number of hip replacement surgeries, and advances in the femoral stem. However, high cost of hip replacement surgeries and declining reimbursements, shortage of skilled orthopedic surgeons, and limitations of femoral stems may hamper the growth of the femoral stems industry over the forecast period.
Global Femoral Stems Market: Overview
Advances in femoral stems
Femoral stems have undergone significant improvements in terms of material and design. The use of tapered titanium stems has outplaced coated cobalt-chromium stems. Tapered titanium stems offer ease of insertion, less-stress shielding, less blood loss, less thigh pain, leading to short hospital stays. Thus, manufacturers have increased R&D efforts to introduce femoral stems with advanced designs and materials, making them more durable, long-lasting, and dependable. This will lead to the expansion of the global femoral stems market at a CAGR of nearly 4% during the forecast period.
The increasing demand for short stems among young patients
As many young and active patients are undergoing hip replacement, there is an increasing demand for implants that are durable, highly functional, and amenable for future successful revision. Short stems can be easily inserted through minimally inserted surgeries (MIS) and require less bone removal. They reduce or eliminate anterior thigh pain, facilitate physiological proximal bone loading providing better pain relief, radiographic stability, and improved functions. This development is expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of several major players, the global femoral stems market is moderately concentrated. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of few leading femoral stems manufacturers, that include B. Braun Melsungen AG, Johnson & Johnson Services Inc., Smith & Nephew Plc, Stryker Corp., Zimmer Biomet Holdings Inc.
Also, the femoral stems market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- B. Braun Melsungen AG
- Smith & Nephew Plc
- Stryker Corp.
PART 01: EXECUTIVE SUMMARYPART 07: CUSTOMER LANDSCAPEPART 09: DECISION FRAMEWORK
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY FIXTURE
PART 08: GEOGRAPHIC LANDSCAPE
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSIS
PART 14: APPENDIX
List of Exhibits:
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- B. Braun Melsungen AG
- Smith & Nephew Plc
- Stryker Corp.
The following companies are recognised as the key players in the global femoral stems market: B. Braun Melsungen AG, Johnson & Johnson Services Inc., Smith & Nephew Plc, Stryker Corp., Zimmer Biomet Holdings Inc.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increasing demand for short-stems among young patients.”
According to the report, one of the major drivers for this market is the advances in femoral stems.
Further, the report states that one of the major factors hindering the growth of this market is the high cost of hip replacement surgeries and declining reimbursements.
The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increasing demand for short-stems among young patients.”
According to the report, one of the major drivers for this market is the advances in femoral stems.
Further, the report states that one of the major factors hindering the growth of this market is the high cost of hip replacement surgeries and declining reimbursements.
The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- B. Braun Melsungen AG
- Johnson & Johnson Services Inc.
- Smith & Nephew Plc
- Stryker Corp.
- Zimmer Biomet Holdings Inc.
Note: Product cover images may vary from those shown
